677 related articles for article (PubMed ID: 21623557)
41. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
Berchi C; Bouvier V; Réaud JM; Launoy G
Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
[TBL] [Abstract][Full Text] [Related]
43. Screening for colorectal cancer.
Saliangas K
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
Allameh Z; Davari M; Emami MH
Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
[TBL] [Abstract][Full Text] [Related]
45. What is the most cost-effective screening regimen for colon cancer?
Griffith S; Kane KY
J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
[No Abstract] [Full Text] [Related]
46. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
Heresbach D; Chauvin P; Grolier J; Josselin JM
Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
[TBL] [Abstract][Full Text] [Related]
47. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
Fisher JA; Fikry C; Troxel AB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
49. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
50. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
Ramsey SD; Wilschut J; Boer R; van Ballegooijen M
Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066
[TBL] [Abstract][Full Text] [Related]
51. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
52. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
53. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
van Veen WA
Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
[TBL] [Abstract][Full Text] [Related]
54. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan.
Wharam JF; Graves AJ; Landon BE; Zhang F; Soumerai SB; Ross-Degnan D
Med Care; 2011 Sep; 49(9):865-71. PubMed ID: 21577162
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness of colorectal cancer screening in renal transplant recipients.
Wong G; Howard K; Craig JC; Chapman JR
Transplantation; 2008 Feb; 85(4):532-41. PubMed ID: 18347531
[TBL] [Abstract][Full Text] [Related]
56. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
Vijan S; Hwang EW; Hofer TP; Hayward RA
Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
[TBL] [Abstract][Full Text] [Related]
57. Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.
Kingsley J; Karanth S; Revere FL; Agrawal D
PLoS One; 2016; 11(12):e0167452. PubMed ID: 27936028
[TBL] [Abstract][Full Text] [Related]
58. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
[TBL] [Abstract][Full Text] [Related]
59. Positive cost effectiveness of early diagnosis of colorectal cancer.
Bolin ; Korman ; Stanton ; Talley ; Newstead ; Donnelly ; Hall ; Ho ; Lapsley
Colorectal Dis; 1999 Mar; 1(2):113-22. PubMed ID: 23577716
[TBL] [Abstract][Full Text] [Related]
60. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
